Thrombotic - Fibrinolytic Balance and ASCVD events

Insights and discussion from the cutting edge with reference to journal articles and other research papers.
BrianR
Senior Contributor
Senior Contributor
Posts: 260
Joined: Tue Oct 02, 2018 12:32 pm
Location: Southeastern Michigan

Thrombotic - Fibrinolytic Balance and ASCVD events

Postby BrianR » Tue Sep 14, 2021 3:37 pm

Paywalled paper: https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehab600/6368900?redirectedFrom=fulltext

Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis
Andrew P DeFilippis, Patrick J Trainor, George Thanassoulis, Lyndia C Brumback, Wendy S Post, Michael Y Tsai, Sotirios Tsimikas Author European Heart Journal, ehab600, Published: 11 September 2021
https://doi.org/10.1093/eurheartj/ehab600


I wasn't able to read the paper, but the information in the abstract is interesting and the graphic is very clear.
Abstract
Aims

Traditional atherosclerotic cardiovascular disease (ASCVD) risk factors fail to address the full spectrum of the complex interplay of atherosclerotic and atherothrombotic factors integral to ASCVD events. This study sought to examine the association between atherothrombotic biomarkers and ASCVD events.

Methods and results
The association between atherothrombotic biomarkers and 877 ASCVD events with and without adjustment for traditional risk factors was evaluated via Cox proportional hazards models and factor analysis in 5789 Multi-Ethnic Study of Atherosclerosis participants over a median follow-up of 14.7 years. Factor analysis accounted for multidimensional relationship and shared variance among study biomarkers, which identified two new variables: a thrombotic factor (Factor 1), principally defined by shared variance in fibrinogen, plasmin–antiplasmin complex, factor VIII, D-dimer, and lipoprotein(a), and a fibrinolytic factor (Factor 2), principally defined by shared variance of plasminogen and oxidized phospholipids on plasminogen. In a model including both factors, the thrombotic factor was associated with the higher risk of ASCVD events [hazard ratio (HR) 1.57, 95% confidence interval (CI) 1.45, 1.70], while the fibrinolytic factor was associated with the lower risk of ASCVD events (HR 0.76, 95% CI 0.70, 0.82), with estimated ASCVD free survival highest for low atherothrombotic Factor 1 and high atherothrombotic Factor 2.

Conclusion
Two atherothrombotic factors, one representative of thrombotic propensity and the other representative of fibrinolytic propensity, were significantly and complementarily associated with incident ASCVD events, remained significantly associated with incident ASCVD after controlling for traditional risk factors, and have promise for identifying patients at high ASCVD event risk specifically due to their atherothrombotic profile.
You do not have the required permissions to view the files attached to this post.

Return to “Science and Research”

Who is online

Users browsing this forum: No registered users and 15 guests